Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Uveitis: Know the Risk Factors, Symptoms & Treatment Options

Carina Stanton  |  October 22, 2018

The effects of uveitis are life changing, causing vision damage and even blindness. However, early detection and effective treatment can halt inflammation and protect patients from permanent eye damage and vision loss.

This form of inflammation affects the middle layer of the eye wall, known as the uvea, and is a frequent complication of juvenile idiopathic arthritis (JIA). Idiopathic uveitis may also be diagnosed when no arthritis or other identifiable causes are present.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

“Uveitis is a complication of JIA about which both pediatric and adult rheumatologists must be aware and refer patients for regular screening eye exams,” says Kathleen O’Neil, MD.

As chief of the division of rheumatology and professor of clinical pediatrics at the Indiana University School of Medicine, Dr. O’Neil sees the importance of detecting all forms of pediatric uveitis early and engaging in close collaboration with a patient’s ophthalmologist to coordinate the best treatment, including systemic immunosuppressive therapies when needed to prevent permanent damage.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

She also cautions that uveitis is not only a pediatric concern. “Adult rheumatologists need to be aware of uveitis as a complication of JIA, especially for young adult patients transitioning from pediatric care who may never have had uveitis before, so have stopped routine screening exams. Uveitis can occur for the first time in adulthood.”

To improve uveitis awareness, Dr. O’Neil suggests all rheumatologists have a clear understanding of uveitis risk factors, symptoms and the best treatment options based on long-standing and emerging evidence.

The Risk Factors
Several factors put JIA patients at a higher risk for uveitis. These include the onset of arthritis at an early age, being female and having inflammation of four or fewer joints (i.e., oligoarticular JIA). A positive antinuclear antibody (ANA) test and being African-American or Asian are also risk factors, as well as certain genetic markers (HLA-B27, HLA-DR5 haplotype, HLA-DRB1*1104 allele, and a combination of HLA-DRB1*1104 and HLA-DPB1*0201 alleles).1,2

The Symptoms
The chronic uveitis associated with JIA is usually asymptomatic. In the seronegative spondyloarthropathies, acute uveitis may occur. Common symptoms associated with acute uveitis include eye pain, erythema and photophobia.

“Children with the asymptomatic chronic uveitis may present with vision troubles by putting their face inches from a coloring page they are working on or standing very close to the television. They may also bump into things when they walk and exhibit other signs of visual difficulty,” Dr. O’Neil says. The child with HLA-B27-associated enthesitis-related arthritis (seronegative spondyloarthropathy) may occasionally develop red eye, indicating acute anterior uveitis. These patients are often photophobic. Usually, short-term topical treatment, such as steroid eye drops, controls this form of uveitis.

Page: 1 2 3 | Single Page
Share: 

Filed under:Conditions Tagged with:eyeEye diseaseUveitisvision

Related Articles

    An Overview of Pediatric, Noninfectious Uveitis

    October 18, 2018

    Uveitis is an inflammation of the uvea, which comprises the iris, ciliary body and choroid. Uveitis can lead to ocular damage and complete visual loss. Noninfectious etiologies for uveitis are the most common in the U.S.1 The estimated incidence of uveitis ranges from 25–52 per 100,000 in adults and five per 100,000 in children. The…

    How HLA-B27 Research Landmarks, Advances Relate to Ankylosing Spondylitis Pathogenesis

    How HLA-B27 Research Landmarks, Advances Relate to Ankylosing Spondylitis Pathogenesis

    July 13, 2016

    The mechanistic link between human leukocyte antigen B27 (HLA-B27) and ankylosing spondylitis (AS) is one of the great enigmas in rheumatology. The introduction of biological therapies that target tumor necrosis factor (TNF) or the interleukin (IL) 23/IL-17A axis has had a major impact on the quality of life for many patients with AS, and one…

    Watch Those Eyes

    December 1, 2007

    What you need to know about Uveitis in Rheumatic Diseases

    Oksana Kuzmina/shutterstock.comx

    Environmental Factors in Pediatric Systemic Autoimmune Diseases

    March 20, 2017

    Systemic autoimmune diseases are thought to result from immune dysregulation in genetically susceptible individuals who were exposed to environmental risk factors. Many studies have identified genetic risk factors for these diseases, but concordance rates among monozygotic twins are 25–40%, suggesting that nonheritable environmental factors play a more prominent role.1,2 Through carefully conducted epidemiologic and other…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences